These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22503752)

  • 1. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
    Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
    Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.
    Vilgelm A; Lian Z; Wang H; Beauparlant SL; Klein-Szanto A; Ellenson LH; Di Cristofano A
    Cancer Res; 2006 Apr; 66(7):3375-80. PubMed ID: 16585156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
    Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
    Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
    Lian Z; De Luca P; Di Cristofano A
    J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma.
    Joshi A; Ellenson LH
    Exp Cell Res; 2011 Jul; 317(11):1580-9. PubMed ID: 21397598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.
    Lee H; Choi HJ; Kang CS; Lee HJ; Lee WS; Park CS
    Mod Pathol; 2012 Nov; 25(11):1508-15. PubMed ID: 22766795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid estrogen signaling negatively regulates PTEN activity through phosphorylation in endometrial cancer cells.
    Scully MM; Palacios-Helgeson LK; Wah LS; Jackson TA
    Horm Cancer; 2014 Aug; 5(4):218-31. PubMed ID: 24844349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
    Shawana S; Kehar SI; Masood S; Aamir I
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma.
    Gotoh O; Sugiyama Y; Tonooka A; Kosugi M; Kitaura S; Minegishi R; Sano M; Amino S; Furuya R; Tanaka N; Kaneyasu T; Kumegawa K; Abe A; Nomura H; Takazawa Y; Kanao H; Maruyama R; Noda T; Mori S
    J Pathol; 2024 Jul; 263(3):275-287. PubMed ID: 38734880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
    Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
    Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
    Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production.
    Pan J; Cheng L; Bi X; Zhang X; Liu S; Bai X; Li F; Zhao AZ
    Sci Rep; 2015 Oct; 5():14958. PubMed ID: 26468779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
    Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
    Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
    Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
    Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
    Gao Y; Lin P; Lydon JP; Li Q
    J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.